Drugs Made In America Acquisition Corp. Units (DMAAU) NASDAQ
10.50
-0.0501(-0.47%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
10.50
-0.0501(-0.47%)
Currency In USD
| Market Cap | 85.37M |
| Enterprise Value | 85.37M |
| P/E Ratio | 42.21 |
| PEG Ratio | 688.69 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.05 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -484.85 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | 0.02 |
| Return On Equity | 0.03 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | -479 |
| Diluted EPS | -0.06 |
| Total Cash | 717 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.06 |
| Book Value Per Share | 10.01 |
| 52-Week Change | 3.75 |
| 52-Week High | 10.6 |
| 52-Week Low | 10 |
| Moving Average 50 Days | 10.51 |
| Moving Average 200 Days | 10.34 |
| Average Volume | 7,333 |
| Shares Outstanding | 23.43M |
| % Held by Institutions | 2.45 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |